Norgesic Forte (Orphenadrine Citrate, Aspirin and Caffeine)
**Product type:** Human Prescription Drug
**Active ingredient:** ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
**Strength:** 770; 60; 50 mg/1; mg/1; mg/1
**Dosage form:** Tablet, Multilayer
**Route:** Oral
**Labeler:** Poly Pharmaceuticals, Inc.
**Marketing category:** ANDA (ANDA075141)
**Pharmacologic class:** Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
/api/v1/systems/ndc_fda/nodes/50991-999Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.